Canalia Capsule is the only US FDA approved Proton Pump Inhibitor formulated with Dual Delayed Release (DDR) technology that ensures both faster and longest action. Canalia Capsule ensures 24-hour heartburn free periods and with just one capsule provides similar effects as twice-daily conventional Proton Pump Inhibitors. Canalia Capsule is safe for cardiac patients as Dexlansoprazole has no clinically important effect on the active metabolite of Clopidogrel. It is a novel Proton Pump Inhibitor which doesn’t prolong QT intervals in healthy participants and is well-tolerated. So it is considered safe even for cardiac patients.
FR
DE